Initial small trials from 2016 to 2017, including EXSCEL, FIGHT, and LIVE, were not supportive of the use of GLP-1RAs in HFrEF with negative outcomes related to cardiovascular events [53,54,55]
Compounded oral drops have no reliable head-to-head data proving equivalent weight-loss outcomes to the branded injectables
[2] [5] At present, there are no GLP-1 patches licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) or approved by the National Institute for Health and Care Excellence (NICE) for routine use in the United Kingdom (as verified through MHRA and Electronic Medicines Compendium searches, January 2024)
May your receptors stay responsive, your titrations stay smooth, and your results stay consistent.
Here are some of the most common causes